View Clinical Trial (Medical Research Study)
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients - NCT00806026-33143B(Clinical Trial 315663)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
South Miami |
|
State:
|
|
FL |
| Zip Code: |
|
33143 |
| Conditions: |
|
Idiopathic Restless Legs Syndrome |
| Purpose: |
|
This purpose of this study is to investigate the efficacy and tolerability of pregabalin in
treating idiopathic RLS patients for up to 12 months.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- idiopathic RLS with the presence of all four clinical manifestations of RLS
- RLS symptoms occur predominantly in the evening
- RLS history at least 6 months
- IRLS => 15 at the beginning and the end of placebo run-in
- Have =>15 nights with RLS symptoms in the month prior to screening
Exclusion Criteria:
- Any secondary RLS
- Current augmentation due to RLS treatment
- Placebo responders identified during the placebo run-in |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
South Miami, FL 33143
United States
Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|